No Difference in Primary Outcome CLEAR SYNERGY (OASIS 9) is a 2 x 2 randomized controlled trial of low-dose colchicine 0.5 mg daily versus placebo and spironolactone 25 mg daily versus placebo in ...

The standard security screening line for members of the Clear trusted traveler program is moving to the lower level of domestic Terminal North at Hartsfield-Jackson International Airport.

according to results from the CLEAR SYNERGY trial. The findings deliver a second blow to this 2x2 factorial-design trial: last month, results from the colchicine arm of the study showed that giving ...

NEW YORK--(BUSINESS WIRE)--CLEAR, the company building a connected world that’s smarter and more secure through its biometric identity platform, announces a major nationwide sports expansion ...